KEGG   PATHWAY: csab05150
Entry
csab05150                   Pathway                                
Name
Staphylococcus aureus infection - Chlorocebus sabaeus (green monkey)
Description
Staphylococcus aureus can cause multiple forms of infections ranging from superficial skin infections to food poisoning and life-threatening infections. The organism has several ways to divert the effectiveness of the immune system: secreting immune modulating proteins that inhibit complement activation and neutrophil chemotaxis or lysis, modulating the sensitivity to cationic antimicrobial peptides (such as defensin) by increasing the positive net charge of its cytoplasmic membrane, and expression of superantigens that prevent development of a normal immune response or cause an emetic response when ingested.
Class
Human Diseases; Infectious disease: bacterial
Pathway map
csab05150  Staphylococcus aureus infection
csab05150

Organism
Chlorocebus sabaeus (green monkey) [GN:csab]
Gene
103243860  keratin, type I cytoskeletal 42-like [KO:K07604]
103243443  KRT14; keratin 14 [KO:K07604]
103243444  KRT16; keratin 16 [KO:K07604]
103243446  keratin, type I cytoskeletal 17 [KO:K07604]
103243448  KRT9; keratin 9 [KO:K07604]
103243449  KRT19; keratin 19 [KO:K07604]
103243450  KRT15; keratin 15 [KO:K07604]
103243451  KRT13; keratin 13 [KO:K07604]
103243452  KRT36; keratin 36 [KO:K07604]
103243453  KRT35; keratin 35 [KO:K07604]
103243454  KRT32; keratin 32 [KO:K07604]
103243456  keratin, type I cuticular Ha7-like [KO:K07604]
103243457  KRT38; keratin 38 [KO:K07604]
103243458  keratin, type I cuticular Ha7-like [KO:K07604]
103243459  keratin, type I cuticular Ha1 [KO:K07604]
103243460  KRT34; keratin 34 [KO:K07604]
103243461  KRT33B; keratin 33B [KO:K07604]
103243462  keratin, type I cuticular Ha3-I [KO:K07604]
103243486  KRT10; keratin 10 [KO:K07604]
103243488  KRT12; keratin 12 [KO:K07604]
103243489  KRT20; keratin 20 [KO:K07604]
103243491  KRT23; keratin 23 [KO:K07604]
103243492  KRT39; keratin 39 [KO:K07604]
103243493  KRT40; keratin 40 [KO:K07604]
103243501  KRT24; keratin 24 [KO:K07604]
103243503  KRT25; keratin 25 [KO:K07604]
103243505  KRT27; keratin 27 [KO:K07604]
103243506  KRT28; keratin 28 [KO:K07604]
103238803  keratin, type I cytoskeletal 18 [KO:K07604]
103239494  KRT18; keratin 18 [KO:K07604]
103236421  FGG; fibrinogen gamma chain [KO:K03905]
103234342  C3; complement C3 [KO:K03990]
108449896  CFB; complement factor B [KO:K01335] [EC:3.4.21.47]
103233571  CFD; complement factor D [KO:K01334] [EC:3.4.21.46]
103230382  CFH; complement factor H [KO:K04004]
103215928  mannose-binding protein A-like [KO:K03991]
103216183  MBL2; mannose binding lectin 2 [KO:K03991]
103241880  MASP1; mannan binding lectin serine peptidase 1 [KO:K03992] [EC:3.4.21.-]
103225618  MASP2; mannan binding lectin serine peptidase 2 [KO:K03993] [EC:3.4.21.104]
103229828  putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 [KO:K06856]
103224088  uncharacterized LOC103224088 [KO:K06856]
103229820  putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 [KO:K06856]
103229838  putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 [KO:K06856]
103229839  uncharacterized LOC103229839 [KO:K06856]
103229845  putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 [KO:K06856]
103229849  putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 [KO:K06856]
103229850  putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 [KO:K06856]
103229864  uncharacterized LOC103229864 [KO:K06856]
103247608  uncharacterized LOC103247608 [KO:K06856]
103229935  uncharacterized LOC103229935 [KO:K06856]
103229939  putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 [KO:K06856]
103229942  uncharacterized LOC103229942 [KO:K06856]
103229943  uncharacterized LOC103229943 [KO:K06856]
103225410  C1QA; complement C1q A chain [KO:K03986]
103225408  C1QB; complement C1q B chain [KO:K03987]
103225409  C1QC; complement C1q C chain [KO:K03988]
103218858  C1R; complement C1r [KO:K01330] [EC:3.4.21.41]
103218499  complement C1s subcomponent [KO:K01331] [EC:3.4.21.42]
103218857  C1S; complement C1s [KO:K01331] [EC:3.4.21.42]
103221735  C2; complement component 2 [KO:K01332] [EC:3.4.21.43]
103221723  C4B; complement component 4B [KO:K03989]
103221732  complement C4-A-like [KO:K03989]
103218914  C5; complement C5 [KO:K03994]
103218520  C3AR1; complement C3a receptor 1 [KO:K04009]
103234937  C5AR1; complement C5a receptor 1 [KO:K04010]
103247163  high affinity immunoglobulin gamma Fc receptor I [KO:K06498]
103223676  FCGR2A; Fc fragment of IgG receptor IIa [KO:K06472]
103223672  FCGR2B; Fc fragment of IgG receptor IIb [KO:K12560]
103223675  low affinity immunoglobulin gamma Fc region receptor III [KO:K06463]
103235282  FCAR; Fc fragment of IgA receptor [KO:K06513]
103235147  FPR2; formyl peptide receptor 2 [KO:K04173]
103235155  FPR3; formyl peptide receptor 3 [KO:K04173]
103235144  FPR1; formyl peptide receptor 1 [KO:K04172]
103240838  PLG; plasminogen [KO:K01315] [EC:3.4.21.7]
103236106  CFI; complement factor I [KO:K01333] [EC:3.4.21.45]
103239073  SELPLG; selectin P ligand [KO:K06544]
103230618  SELP; selectin P [KO:K06496]
103233893  ICAM1; intercellular adhesion molecule 1 [KO:K06490]
103231906  ITGAL; integrin subunit alpha L [KO:K05718]
103231383  ITGAM; integrin subunit alpha M [KO:K06461]
103220048  ITGB2; integrin subunit beta 2 [KO:K06464]
103215297  DEFB1; defensin beta 1 [KO:K23125]
103215308  DEFB4B; defensin beta 4B [KO:K21100]
103215309  beta-defensin 103 [KO:K23126]
103215303  theta defensin subunit A [KO:K05230]
103215301  defensin-6-like [KO:K05230]
103215304  DEFA1; defensin alpha 1 [KO:K05230]
103247085  neutrophil defensin 4-like [KO:K05230]
103247087  neutrophil defensin 6-like [KO:K05230]
103227575  CAMP; cathelicidin antimicrobial peptide [KO:K13916]
103222580  DSG1; desmoglein 1 [KO:K07596]
103227080  uncharacterized LOC103227080 [KO:K10785]
103227095  uncharacterized LOC103227095 [KO:K10785]
103221682  MHC-DPB1; major histocompatibility complex, class II, DP beta 1 [KO:K06752]
103221683  MHC-DPA1; major histocompatibility complex, class II, DP alpha 1 [KO:K06752]
103221684  MHC-DOA; major histocompatibility complex, class II, DO alpha [KO:K06752]
103221688  MHC-DMA; HLA class II histocompatibility antigen, DM alpha chain [KO:K06752]
103221689  MHC-DMB; major histocompatibility complex, class II, DM beta [KO:K06752]
103221695  MHC-DOB; major histocompatibility complex, class II, DO beta [KO:K06752]
103221696  MHC-DQB1; major histocompatibility complex, class II, DQ beta 1 [KO:K06752]
103221698  MHC-DQA1; major histocompatibility complex, class II, DQ alpha 1 [KO:K06752]
103221700  HLA class II histocompatibility antigen, DRB1-4 beta chain-like [KO:K06752]
103221702  HLA class II histocompatibility antigen, DRB1-4 beta chain [KO:K06752]
103221704  MHC-DRA; major histocompatibility complex, class II, DR alpha [KO:K06752]
103247136  HLA class II histocompatibility antigen, DP alpha 1 chain [KO:K06752]
103247138  HLA class II histocompatibility antigen, DP beta 1 chain-like [KO:K06752]
103247148  HLA class II histocompatibility antigen, DRB1-15 beta chain [KO:K06752]
103225270  PTAFR; platelet activating factor receptor [KO:K04279]
103230190  IL10; interleukin 10 [KO:K05443]
Compound
C11596  FMLP
C20898  Lipoteichoic acid
Reference
  Authors
Foster TJ
  Title
Colonization and infection of the human host by staphylococci: adhesion, survival and immune evasion.
  Journal
Vet Dermatol 20:456-70 (2009)
DOI:10.1111/j.1365-3164.2009.00825.x
Reference
  Authors
Foster TJ
  Title
Immune evasion by staphylococci.
  Journal
Nat Rev Microbiol 3:948-58 (2005)
DOI:10.1038/nrmicro1289
Reference
  Authors
Laarman A, Milder F, van Strijp J, Rooijakkers S
  Title
Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications.
  Journal
J Mol Med 88:115-20 (2010)
DOI:10.1007/s00109-009-0572-y
Reference
  Authors
Rooijakkers SH, van Kessel KP, van Strijp JA
  Title
Staphylococcal innate immune evasion.
  Journal
Trends Microbiol 13:596-601 (2005)
DOI:10.1016/j.tim.2005.10.002
Reference
  Authors
Iwatsuki K, Yamasaki O, Morizane S, Oono T
  Title
Staphylococcal cutaneous infections: invasion, evasion and aggression.
  Journal
J Dermatol Sci 42:203-14 (2006)
DOI:10.1016/j.jdermsci.2006.03.011
Reference
  Authors
Torres BA, Kominsky S, Perrin GQ, Hobeika AC, Johnson HM
  Title
Superantigens: the good, the bad, and the ugly.
  Journal
Exp Biol Med (Maywood) 226:164-76 (2001)
DOI:10.1177/153537020122600303
Reference
  Authors
Atkins KL, Burman JD, Chamberlain ES, Cooper JE, Poutrel B, Bagby S, Jenkins AT, Feil EJ, van den Elsen JM
  Title
S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation.
  Journal
Mol Immunol 45:1600-11 (2008)
DOI:10.1016/j.molimm.2007.10.021
Reference
  Authors
Silverman GJ, Goodyear CS
  Title
Confounding B-cell defences: lessons from a staphylococcal superantigen.
  Journal
Nat Rev Immunol 6:465-75 (2006)
DOI:10.1038/nri1853
Reference
  Authors
Goodyear CS, Silverman GJ
  Title
Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes.
  Journal
Proc Natl Acad Sci U S A 101:11392-7 (2004)
DOI:10.1073/pnas.0404382101
Reference
  Authors
Haupt K, Reuter M, van den Elsen J, Burman J, Halbich S, Richter J, Skerka C, Zipfel PF
  Title
The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b.
  Journal
PLoS Pathog 4:e1000250 (2008)
DOI:10.1371/journal.ppat.1000250
Reference
  Authors
Bokarewa MI, Jin T, Tarkowski A
  Title
Staphylococcus aureus: Staphylokinase.
  Journal
Int J Biochem Cell Biol 38:504-9 (2006)
DOI:10.1016/j.biocel.2005.07.005
Reference
  Authors
Rooijakkers SH, Ruyken M, Roos A, Daha MR, Presanis JS, Sim RB, van Wamel WJ, van Kessel KP, van Strijp JA
  Title
Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases.
  Journal
Nat Immunol 6:920-7 (2005)
DOI:10.1038/ni1235
Reference
  Authors
Rooijakkers SH, Wu J, Ruyken M, van Domselaar R, Planken KL, Tzekou A, Ricklin D, Lambris JD, Janssen BJ, van Strijp JA, Gros P
  Title
Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.
  Journal
Nat Immunol 10:721-7 (2009)
DOI:10.1038/ni.1756
Reference
  Authors
Jongerius I, Kohl J, Pandey MK, Ruyken M, van Kessel KP, van Strijp JA, Rooijakkers SH
  Title
Staphylococcal complement evasion by various convertase-blocking molecules.
  Journal
J Exp Med 204:2461-71 (2007)
DOI:10.1084/jem.20070818
Reference
  Authors
Hair PS, Ward MD, Semmes OJ, Foster TJ, Cunnion KM
  Title
Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b.
  Journal
J Infect Dis 198:125-33 (2008)
DOI:10.1086/588825
Reference
  Authors
Higgins J, Loughman A, van Kessel KP, van Strijp JA, Foster TJ
  Title
Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes.
  Journal
FEMS Microbiol Lett 258:290-6 (2006)
DOI:10.1111/j.1574-6968.2006.00229.x
Reference
  Authors
Laursen NS, Gordon N, Hermans S, Lorenz N, Jackson N, Wines B, Spillner E, Christensen JB, Jensen M, Fredslund F, Bjerre M, Sottrup-Jensen L, Fraser JD, Andersen GR
  Title
Structural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureus.
  Journal
Proc Natl Acad Sci U S A 107:3681-6 (2010)
DOI:10.1073/pnas.0910565107
Reference
  Authors
Ramsland PA, Willoughby N, Trist HM, Farrugia W, Hogarth PM, Fraser JD, Wines BD
  Title
Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1.
  Journal
Proc Natl Acad Sci U S A 104:15051-6 (2007)
DOI:10.1073/pnas.0706028104
Reference
  Authors
de Haas CJ, Veldkamp KE, Peschel A, Weerkamp F, Van Wamel WJ, Heezius EC, Poppelier MJ, Van Kessel KP, van Strijp JA
  Title
Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.
  Journal
J Exp Med 199:687-95 (2004)
DOI:10.1084/jem.20031636
Reference
  Authors
Prat C, Bestebroer J, de Haas CJ, van Strijp JA, van Kessel KP
  Title
A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1.
  Journal
J Immunol 177:8017-26 (2006)
DOI:10.4049/jimmunol.177.11.8017
Reference
  Authors
Bestebroer J, Poppelier MJ, Ulfman LH, Lenting PJ, Denis CV, van Kessel KP, van Strijp JA, de Haas CJ
  Title
Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling.
  Journal
Blood 109:2936-43 (2007)
DOI:10.1182/blood-2006-06-015461
Reference
  Authors
Chung MC, Wines BD, Baker H, Langley RJ, Baker EN, Fraser JD
  Title
The crystal structure of staphylococcal superantigen-like protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition.
  Journal
Mol Microbiol 66:1342-55 (2007)
DOI:10.1111/j.1365-2958.2007.05989.x
Reference
  Authors
Chavakis T, Hussain M, Kanse SM, Peters G, Bretzel RG, Flock JI, Herrmann M, Preissner KT
  Title
Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes.
  Journal
Nat Med 8:687-93 (2002)
DOI:10.1038/nm728
Reference
  Authors
Li M, Lai Y, Villaruz AE, Cha DJ, Sturdevant DE, Otto M
  Title
Gram-positive three-component antimicrobial peptide-sensing system.
  Journal
Proc Natl Acad Sci U S A 104:9469-74 (2007)
DOI:10.1073/pnas.0702159104
Reference
  Authors
Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J
  Title
Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases.
  Journal
Antimicrob Agents Chemother 48:4673-9 (2004)
DOI:10.1128/AAC.48.12.4673-4679.2004
Reference
  Authors
Fraser JD, Proft T
  Title
The bacterial superantigen and superantigen-like proteins.
  Journal
Immunol Rev 225:226-43 (2008)
DOI:10.1111/j.1600-065X.2008.00681.x
Reference
  Authors
Yamaguchi T, Nishifuji K, Sasaki M, Fudaba Y, Aepfelbacher M, Takata T, Ohara M, Komatsuzawa H, Amagai M, Sugai M
  Title
Identification of the Staphylococcus aureus etd pathogenicity island which encodes a novel exfoliative toxin, ETD, and EDIN-B.
  Journal
Infect Immun 70:5835-45 (2002)
DOI:10.1128/IAI.70.10.5835-5845.2002
Reference
  Authors
Pazgier M, Hoover DM, Yang D, Lu W, Lubkowski J
  Title
Human beta-defensins.
  Journal
Cell Mol Life Sci 63:1294-313 (2006)
DOI:10.1007/s00018-005-5540-2
Reference
  Authors
Zhang Q, Mousdicas N, Yi Q, Al-Hassani M, Billings SD, Perkins SM, Howard KM, Ishii S, Shimizu T, Travers JB
  Title
Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor.
  Journal
J Clin Invest 115:2855-61 (2005)
DOI:10.1172/JCI25429
Reference
  Authors
Lehrer RI
  Title
Primate defensins.
  Journal
Nat Rev Microbiol 2:727-38 (2004)
DOI:10.1038/nrmicro976
Related
pathway
csab04610  Complement and coagulation cascades
csab04660  T cell receptor signaling pathway
csab04662  B cell receptor signaling pathway
KO pathway
ko05150   
LinkDB

DBGET integrated database retrieval system